Your team consists of an MD, 2 ARNP’s, and 2 psychotherapists. Each of our ketamine assisted psychotherapy (KAP) programs consist of an initial intake by an MD or Nurse Practitioner in which you will be screened medically and psychologically to determine if this treatment is appropriate for you.
If appropriate, KAP begins with a preparation appointment where we work with you to help you set an intention for your treatment. We will discuss with you what to expect, dietary and medication considerations, as well as before and aftercare.
After the initial intake and preparation appointment, you will be placed into a 6-week program in which ketamine-assisted therapy will be provided in either one of the following ways:
- Deep Dive KAP session: intramuscular (IM) ketamine-assisted psychotherapy session. Each session is approximately 120 minutes. After every ketamine-assisted psychotherapy session, there is an integration follow up session
- Lower dose KAP session: intramuscular (IM) ketamine-assisted psychotherapy session. Each session is 120 minutes. After every KAP session, there is an integration follow up session.
After completing your individual KAP program, if appropriate, you may have the option to join our Group KAP program.
While enrolled in any of our KAP programs, we offer a bi-weekly KAP Integration Group. It helps to solidify insights, build support/community, and increase connection. Although this is optional it is STRONGLY recommended to optimize the benefits of KAP.
|KAP Session||Price per session||Late Cancellation Fee
(Within 48 hours of Visit)
*Ketamine-assisted psychotherapy and ketamine for pain are currently considered experimental therapies by major insurance companies. AIMS Institute can directly bill insurance companies we are contracted with for medical/psychiatric screening, preparation, integration, and psychotherapy visits. For experiential ketamine-assisted therapy sessions, fees will be collected at the time of service. For Tele-KAP, $250 fee is also applied for session ended due to early technical failure.
Other KAP Resources
This list is by no means exhaustive, but represents a variety of different resources about the therapeutic usage of ketamine.
- Ketamine Stirs Up Hope as a Depression Drug – Wired Magazine
- Can we Stop Suicides? – New York Times
- Psychedelics Promote Structural and Functional Neural Plasticity – Cell Report – Ly et al
- Ketamine acts fast to treat depression and its effects last — but how? – Summary of University of Chicago Study in Science Daily Magazine
- Efficacy of Ketamine in the Rapid Treatment of Major Depressive Disorder: a meta-analysis of randomized double-blind, placebo-controlled studies
- Ketamine for Depression by Dr. Stephen Hyde
- The Ketamine Papers by Drs. Wolfson and Hartelius
- Ketamine-Assisted Psychotherapy: Technology for Accessing Non-Ordinary States of Consciousness by Eric Sienknecht of the Polaris Insight Center
- Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy by Dore et al.
- Near-Death Experiences Bear an Uncanny Similarity to Ketamine Trips – Alternet
- Pain News Network: How Ketamine Infusions Helped Me
Ketamine-Assisted Integrative Psychotherapy
Ketamine is an extremely interesting compound invented in 1962 at Parke-Davis. It has been used in clinical practice around the world for over 50 years and is on the WHO list of Essential Medicines. Its primary use has been as a general anesthetic, but also it has been used to induce procedural conscious sedation, as a potent non-opioid analgesic in acute and chronic pain, as a neuroprotective agent to prevent brain damage, as an anxiolytic to control pre-operative and end-of-life anxiety, and as a rapid-onset antidepressant to treat chronic depression and other treatment-resistant mental health conditions. Like many psychedelic substances, it can be used to enhance psychotherapy sessions, to help to facilitate therapeutic trances and persistent transformations to overcome chronic pain, depression, anxiety, existential anxiety, eating disorders, post-traumatic and complex trauma disorders, and for spiritual and psychological growth and deepening somatic awareness (The Ketamine Papers: Science, Therapy, and Transformation, eds. Wolfson & Hartelius, 2016). Our team has collectively 100’s of contact hours of accredited training. Our medical doctor has been utilizing ketamine in practice for 11 months and has completed 86 hours of accredited training in Ketamine: Ketamine Assisted Psychotherapy (Ketamine Training Center, 30 hours), KRIYA Ketamine Research Institute (16 hours), Orenda Institute Ketamine Assisted Psychotherapy (40 hours). Our registered nurse has completed 70 hours: Ketamine Assisted Psychotherapy (Ketamine Training Center, 30 hours) and Orenda Institute Ketamine Assisted Psychotherapy (40 hours). Our doctor of nursing practice has completed 32 hours at the KRIYA Ketamine Research Institute.
Our terms “therapy” and “clinic” and our symbol of medicine with a snake wrapping around a staff all originate from the activities of the Aesclepian healing temples in Ancient Greece. They practiced healing through trance induction.
We are offering this treatment through prescription of compounded lozenges and via intramuscular injection. We create a comfortable and soothing environment via relaxing music, eyeshades, aromatherapy, and soft lighting. We prescribe lozenges for patients to take home for further sessions. We offer this as part of individual and group medical visits and integrate psychotherapy throughout the course of treatment. We are extremely interested in integrating this therapeutic approach for patients facing serious illness to track any improvements in palliation and/or disease-modification that could be correlated or directly reported by patients.